Evidence map›Paper›PMID 25920443›Full record

GuidelineJournal of cardiovascular translational research2015

2015 Guidelines for Establishing Genetically Modified Rat Models for Cardiovascular Research.

Michael J Flister, Jeremy W Prokop, Jozef Lazar, Mary Shimoyama, Melinda Dwinell, Aron Geurts, International Committee on Standardized Genetic Nomenclature for Mice, Rat Genome and Nomenclature Committee

Open access · greenAbstract readGuidelineReview
In one paragraph

Guideline in Journal of cardiovascular translational research, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
1.2field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 24 citations in OpenAlex.

  1. Mapping of EFO terms from the GWAS catalog data to multiple ontologies at the Rat Genome Database.Database : the journal of biological databases and curation · 2026
    Article
  2. Article
  3. Article
  4. Reducing Senescent Cell Burden in Aging and Disease.Trends in molecular medicine · 2020
    Review
  5. Review
  6. Review
  7. Mapping genetic modifiers of radiation-induced cardiotoxicity to rat chromosome 3.American journal of physiology. Heart and circulatory physiology · 2019
    Article
  8. Mapping Mammary Tumor Traits in the Rat.Methods in molecular biology (Clifton, N.J.) · 2019
    Review
  9. Review
  10. From engineering to editing the rat genome.Mammalian genome : official journal of the International Mammalian Genome Society · 2017
    Review
  11. A Natural Model of Mouse Cardiac Myocyte Senescence.Journal of cardiovascular translational research · 2016
    Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Michael J FlisterHuman and Molecular Genetics Center, Medical College of Wisconsin, 8701 Watertown Plank Road, Milwaukee, 53226, WI, USA, mflister@mcw.edu.
Jeremy W Prokop
Jozef Lazar
Mary Shimoyama
Melinda Dwinell
Aron Geurts
International Committee on Standardized Genetic Nomenclature for Mice
Rat Genome and Nomenclature Committee
Medical College of Wisconsin · US

Funding

RAT GENOME DATABASER01HL064541 · NHLBI · MEDICAL COLLEGE OF WISCONSIN · PI ANNE E. KWITEK · 1999 to 2026
$50.0M
Leveraging genetic mapping for personalized targeting of breast cancer microenvironmentR01CA193343 · NCI · MEDICAL COLLEGE OF WISCONSIN · PI Amit Joshi · 2015 to 2026
$3.5M
Advanced genetic engineering technology developmentDP2OD008396 · OD · MEDICAL COLLEGE OF WISCONSIN · PI GEURTS, ARON M · 2011 to 2011
$2.3M
Using a Sequence-to-Structure-to-Function Approach to Functionally Characterize Protein Coding Missense Mutations in the Human and Rat GenomesK01ES025435 · NIEHS · MICHIGAN STATE UNIVERSITY · PI PROKOP, JEREMY WILLIAM · 2014 to 2018
$489k
NCI NIH HHS R01 CA193343NCI NIH HHS R01CA193343NHLBI NIH HHS L30 HL125010NHLBI NIH HHS R01 HL064541NIDDK NIH HHS L30 DK096592NIEHS NIH HHS K01 ES025435NIEHS NIH HHS K01ES025435NIH HHS DP2 OD008396NIH HHS DP2OD008396
6 · The paper itself

Abstract

The rat has long been a key physiological model for cardiovascular research, most of the inbred strains having been previously selected for susceptibility or resistance to various cardiovascular diseases (CVD). These CVD rat models offer a physiologically relevant background on which candidates of human CVD can be tested in a more clinically translatable experimental setting. However, a diverse toolbox for genetically modifying the rat genome to test molecular mechanisms has only recently become available. Here, we provide a high-level description of several strategies for developing genetically modified rat models of CVD.

Indexed as

AnimalsBiomedical ResearchCardiovascular DiseasesDisease Models, AnimalGene Expression RegulationGenetic MarkersGenetic Predisposition to DiseaseGenetic TechniquesHumansPhenotypeRatsRats, TransgenicSpecies SpecificityGenetic Markers

Identifiers

PMID25920443
PMCPMC4475456
OpenAlexW2023760353

What Socratic holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.